AbbVie, Inc. (ABBV)
215.74
+2.62
(+1.23%)
USD |
NYSE |
May 27, 11:54
AbbVie Cash from Investing (Quarterly) : -574.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Biogen, Inc. | -209.50M |
| Gilead Sciences, Inc. | 1.77B |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.829B |
| Cash from Financing (Quarterly) | 919.00M |
| Free Cash Flow | 19.98B |
| Free Cash Flow Per Share (Quarterly) | 2.009 |
| Free Cash Flow to Equity (Quarterly) | -1.109B |
| Free Cash Flow to Firm (Quarterly) | 4.074B |
| Free Cash Flow Yield | 5.22% |